Inhibitory Properties of Functional Food Plants on CYP Enzymes and Cree Traditional Medicines on Aldose Reductase

Inhibitory Properties of Functional Food Plants on CYP Enzymes and Cree Traditional Medicines on Aldose Reductase

Show other versions (3)

This thesis examines the cytochrom P450 (CYP) drug metabolizing enzyme inhibition and antimicrobial properties of 46 common food plants available in the Canadian Market and the inhibitory properties of 17 traditional Cree antidiabetic medicines on aldose reductase. Inhibitory activity profiles of CY...

Full description

Bibliographic Details
Main Author:	Nguyen, San
Language:	en
Published:	2011
Subjects:	P450 cytochrome drug metabolism antimicrobial microflora bacteria food spices Lamiaceae Apiaceae Fabaceae drug interaction CYP3A4 CYP3A5 CYP3A7 CYP2D6 aldose reductase aldose reductase inhibition diabetes cataract Cree traditional medicine Rhododendron groenlandicum quercetin quercetin glycoside pig eyes lens polyol pathway antidiabetic Labrador Tea
Online Access:	http://hdl.handle.net/10393/20070

Similar Items

Inhibitory Properties of Functional Food Plants on CYP Enzymes and Cree Traditional Medicines on Aldose Reductase
by: Nguyen, San
Published: (2011)

Inhibitory Properties of Functional Food Plants on CYP Enzymes and Cree Traditional Medicines on Aldose Reductase
by: Nguyen, San
Published: (2011)

Inhibitory Properties of Functional Food Plants on CYP Enzymes and Cree Traditional Medicines on Aldose Reductase
by: Nguyen, San
Published: (2011)

INHIBITORY ACTIVITY OF FLAVONOIDS ON THE LENS ALDOSE REDUCTASE OF HEALTHY AND DIABETIC RATS
by: M. T. Goodarzi, et al.
Published: (2006-02-01)

INHIBITORY ACTIVITY OF FLAVONOIDS ON THE LENS ALDOSE REDUCTASE OF HEALTHY AND DIABETIC RATS
by: M. T. Goodarzi, et al.
Published: (2006-05-01)

Research progress on the roles of aldose reductase in diabetic retinopathy
by: Hong-Zhe Li, et al.
Published: (2015-07-01)

Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
by: Sravya Jannapureddy, et al.
Published: (2021-03-01)

The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017-01-01)

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
by: Miriam Saiz-Rodríguez, et al.
Published: (2020-04-01)

Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020-01-01)

Potential Metabolic Drug–Drug Interaction of Citrus aurantium L. (Rutaceae) Evaluating by Its Effect on 3 CYP450
by: Lu Zhou, et al.
Published: (2018-08-01)

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population
by: Jun Hyun Han, et al.
Published: (2015-04-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01)

Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma
by: D. Fanni, et al.
Published: (2016-04-01)

Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo
by: Maria Alice Vieira Willrich
Published: (2011)

Efeitos de hipolipemiantes sobre a expressão de CYP3A4 e CYP3A5 in vitro e in vivo
by: Willrich, Maria Alice Vieira
Published: (2011)

Influência da exposição inalatória a combustíveis automotivos na atividade do CYP3A, CPY2C e CYP2D em ratos tratados com fármacos quirais
by: Juciane Lauren Cavalcanti Cardoso
Published: (2012)

Influência da exposição inalatória a combustíveis automotivos na atividade do CYP3A, CPY2C e CYP2D em ratos tratados com fármacos quirais
by: Cardoso, Juciane Lauren Cavalcanti
Published: (2012)

Influence of quercetin and chrysin on the intestinal permeability of paclitaxel, a substrate of P-glycoprotein and CYP3A4 using in vitro rat gut sacs
by: Ravindra Babu Pingili, et al.
Published: (2019-09-01)

Porcine foetal and neonatal CYP3A liver expression
by: Marie Louise Hiort Hermann, et al.
Published: (2011-05-01)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
by: Xunge Zhang, et al.
Published: (2020-01-01)

In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes
by: Shangchen Xu, et al.
Published: (2020-01-01)

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
by: Yang Li, et al.
Published: (2020-01-01)

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
by: Ning Zhang, et al.
Published: (2019-01-01)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
by: Jinlan Wei, et al.
Published: (2018-01-01)

Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans
by: Johannes Matthaei, et al.
Published: (2020-08-01)

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction
by: Zastrozhin MS, et al.
Published: (2017-12-01)

Association of CYP3A4 and CYP3A5 polymorphisms with Iranian breast cancer patients
by: Elham Badavi, et al.
Published: (2015-07-01)

Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes
by: Qun Zhang, et al.
Published: (2021-05-01)

The influence of CYP2C19*2 and CYP3A5*3 variants on the development of depression and effectiveness of therapy: A preliminary study
by: Rafał Świechowski, et al.
Published: (2021-10-01)

The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?
by: Gaëlle Magliocco, et al.
Published: (2021-02-01)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
by: Su-jie Jia, et al.
Published: (2021-05-01)

Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
by: Masako Yasuhara, et al.
Published: (2016-04-01)

CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study
by: Ning Gao, et al.
Published: (2020-03-01)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
by: Gang Dong, et al.
Published: (2018-01-01)

Investigation of a potential role for aldose reductase AlrA in tetrahydropteridine synthesis in Dictyostelium discoideum Ax2
by: Kim Hye-Lim, et al.
Published: (2017-08-01)